Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.47 | $4.38 | 1.94% | 34.38x | 18.63x | 10.21x | 19.13x | 0.36x | -$74.32M | -4.63% | $83.79M | 0.23 | $1.69B | 41.26 | ||
| CORT | CORCEPT THERAPEUTICS INC | $72.77 | $40.64 | 79.06% | 48.19x | 34.27x | 8.05x | 9.55x | 0.67x | $194.62M | 2.51% | $833.74M | 7.82 | $7.87B | 70.99 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $306.20 | $74.67 | 310.07% | 115.55x | 31.57x | 24.08x | 6.37x | 1.51x | $90.43M | 1.48% | $961.76M | 48.18 | $7.22B | 73.34 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.55 | $8.17 | 212.78% | 116.14x | 82.47x | 6.58x | 13.24x | 1.10x | $59.71M | 1.78% | $243.97M | 1.86 | $3.31B | 70.78 | ||
| RPRX | ROYALTY PHARMA PLC | $67.30 | $35.83 | 87.82% | 43.99x | 12.30x | 11.47x | 3.94x | 0.72x | $2.89B | 9.64% | $9.80B | 21.96 | $46.68B | 44.73 | ||
| KRYS | KRYSTAL BIOTECH INC | $300.88 | $78.94 | 281.16% | 39.28x | 38.40x | 18.95x | 6.21x | 2.18x | $310.08M | 3.48% | $1.44B | 48.48 | $8.46B | 31.87 | ||
| TGTX | TG THERAPEUTICS INC | $59.83 | $23.20 | 157.89% | 19.42x | 58.36x | 10.61x | 15.16x | 2.17x | $17.39M | 0.21% | $604.08M | 4.26 | $9.43B | 67.71 | ||
| ADMA | ADMA BIOLOGICS INC | $12.73 | $7.06 | 80.20% | 16.11x | 15.80x | 5.48x | 6.44x | 1.19x | $132.91M | 4.67% | $438.51M | 1.96 | $2.90B | 11.47 | ||
| HALO | HALOZYME THERAPEUTICS INC | $103.63 | $76.53 | 35.41% | 24.44x | 11.44x | 6.54x | -213.89x | 0.56x | $885.88M | 7.51% | -$55.24M | -0.49 | $14.03B | 17.42 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $234.76 | $133.57 | 75.76% | 64.49x | 15.36x | 3.22x | 3.59x | 0.62x | $1.65B | 10.88% | $4.19B | 64.79 | $18.66B | 16.28 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $93.86 | $14.92 | 528.89% | 65.64x | 71.52x | 7.76x | 10.38x | 3.55x | $197.20M | 2.69% | $710.19M | 9.08 | $7.30B | 48.03 | ||
| VCEL | VERICEL CORP | $54.62 | $8.72 | 526.08% | 82.76x | 72.36x | 8.62x | 7.26x | 3.00x | $57.89M | 2.07% | $384.17M | 7.51 | $2.74B | 50.89 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.09 | $148.72 | 267.88% | 34.91x | 29.44x | 10.71x | 6.63x | 2.27x | $3.20B | 2.31% | $20.91B | 82.48 | $140.21B | 27.84 | ||
| INCY | INCYTE CORP | $119.65 | $54.47 | 119.65% | 57.25x | 34.67x | 4.05x | 4.32x | 0.82x | $684.87M | 2.82% | $5.64B | 27.76 | $21.14B | 23.57 | ||
| TECH | BIO-TECHNE CORP | $72.78 | $16.52 | 340.59% | 66.16x | 35.04x | 9.29x | 5.28x | 1.98x | $308.20M | 2.70% | $2.17B | 13.81 | $11.37B | 34.06 | ||
| EXEL | EXELIXIS INC | $69.57 | $32.27 | 115.56% | 20.17x | 19.87x | 6.88x | 9.26x | 1.35x | $1.16B | 6.76% | $1.83B | 7.43 | $16.83B | 15.06 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.59 | $8.11 | 42.97% | 9.13x | 10.15x | 4.66x | 2.89x | 1.75x | $87.07M | 12.65% | $238.92M | 4.02 | $568.74M | 5.92 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.11 | $28.98 | 14.25% | 10.72x | 8.63x | 1.95x | 1.81x | 0.71x | $322.93M | 16.70% | $1.07B | 18.36 | $1.45B | 5.33 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $904.35 | $500.46 | 80.70% | 19.24x | 12.88x | 5.44x | 2.79x | 1.00x | $3.83B | 4.16% | $33.50B | 329.39 | $92.60B | 14.82 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $2.88 | $6.47 | -55.50% | 4.88x | -70.59x | N/A | 2.23x | 0.24x | -$21.06M | -3.96% | $139.32M | 0.76 | $302.74M | 240.85 | ||
| UTHR | UNITED THERAPEUTICS CORP | $562.02 | $215.41 | 160.91% | 19.67x | 20.99x | 7.53x | 3.81x | 2.19x | $867.20M | 3.61% | $6.28B | 146.98 | $22.75B | 14.08 | ||
| VCYT | VERACYTE INC | $24.16 | $9.89 | 144.34% | 15.19x | 12.34x | 3.34x | 1.36x | 3.25x | $161.95M | 8.33% | $1.43B | 17.80 | $1.79B | 12.55 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.